Interscience Laboratories Inc.

Private Company, Headquarters Location
199 Weymouth St., Rockland, MA 02370, United States
(781)792-2133, http://www.intersciencelab.com

Primary SIC: Laboratory Apparatus & Furniture, Primary NAICS: Laboratory Apparatus and Furniture Manufacturing
Description: Manufacturing: Manufactures lab equipment.

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

Interscience Laboratories Inc., News and Information

Idera Pharmaceuticals Reports Positive Interim Data from Phase 1 Clinical Trial of IMO-2125
Wireless News; 12/28/2009; 1182 words; ...2125Type: NewsIdera Pharmaceuticals, Inc. has announced positive interim results...conducted at six U.S. sites with a central laboratory for safety, immunology, and HCV RNA...cells (pDCs) (data presented at 47th Interscience Conference on Antimicrobial Agents and...

Idera Pharmaceuticals Releases Positive Interim Data from Phase 1 Clinical Trial of IMO-2125.
Health & Beauty Close-Up; 12/24/2009; 1456 words; Idera Pharmaceuticals, Inc. has announced positive interim results...at six U.S. sites with a central laboratory for safety, immunology, and HCV...pDCs) (data presented at 47th Interscience Conference on Antimicrobial Agents...

Idera Pharmaceuticals Announces Positive Interim Data from Phase 1 Clinical Trial of IMO-2125 in Chronic Hepatitis C Patients.
Business Wire; 12/21/2009; 1886 words; ...Mass. -- Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today announced positive...conducted at six U.S. sites with a central laboratory for safety, immunology, and HCV RNA...pDCs) (data presented at 47(th) Interscience Conference on Antimicrobial Agents and...

Forest Laboratories Presents Analysis of Two Positive Pivotal Phase III Studies of Ceftaroline for the Treatment of Community-Acquired Pneumonia (CAP) at ICAAC.
Heart Disease Weekly; 11/22/2009; 2130 words; Forest Laboratories, Inc (NYSE: FRX) presented at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy...owned anti-infectives subsidiary of Forest Laboratories, Inc. "The continuing medical need to deal with...

New Results from Study for Monitoring Antimicrobial Resistance Trends (SMART) Show Rates of In Vitro Susceptibility of E. coli Isolates to Commonly Used Antibiotics.
Women's Health Weekly; 11/19/2009; 3016 words; ...from Merck & Co., Inc.'s 2008 Study for Monitoring...presented at the 49th Interscience Conference on Antimicrobial...in accordance with Clinical Laboratory Standards Institute (CLSI...and analyzed by a central laboratory, which confirmed identifications...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.